RecruitingPhase 2Phase 3NCT07542808
An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis
Sponsor
Cellcolabs Clinical SPV Limited
Enrollment
140 participants
Start Date
Apr 27, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
StromaForte injection for knee OA
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Hyaluronic Acid (HA) and Mesenchymal Stem Cells (MSC) for people with knee arthritis, osteoarthritis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERMesenchymal Stem Cells (MSC)
StromaForte
OTHERHyaluronic Acid (HA)
Hyaluronic Acid
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07542808
Related Trials
The Effect of Lipedema on Knee Osteoarthritis
NCT075755552 locations
Perturbation Based Balance Training Versus Progressive Neuromuscular Training as an Adjunct to Conventional Physiotherapy for Pain Reduction and Functional Improvement in Knee Osteoarthritis
NCT076538411 location
Effects of Mobilized Balance Platform Exercises on Balance Parameters in Patients With Knee Osteoarthritis
NCT075754251 location
Knee Osteoarthritis Rehab: High-Intensity Laser vs Classical Modalities
NCT075512451 location
Knee Osteoarthritis Rehabilitation Through Rotational Inertia
NCT074243521 location